A YOUNG man tragically died from an asthma attack after the cost of his inhaler skyrocketed from $66 to $500, according to a lawsuit filed by his family. Cole Schmidtknecht, 22, had battled ...
Specifically, Dupixent is approved to treat moderate to severe asthma that is either: dependent on treatment with an oral corticosteroid, or eosinophilic (caused by an increase in eosinophils ...
has been studied in severe asthmatics and in COPD patients with a history of asthma, showing an additional bronchodilator effect on top of the current asthma treatment. The first large study on ...